Fundraising Fox
Aidence
Amsterdam, NL · 8 known investors
Find your way into Aidence
Sign up to see every warm intro you have to Aidence
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aidence team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aidence, founded in 2015 in Amsterdam, was a radiology AI company that built clinical applications to help radiologists and physicians interpret medical images, focused on pulmonary nodule management and lung cancer screening. Its main product, Veye Lung Nodules (now DeepHealth Lung), was a CE-marked AI solution for lung nodule detection, classification, quantification, and growth assessment; the company was acquired by RadNet in 2022 and integrated into DeepHealth.
Founders & leadership
Investors · 8
How we know: HENQ Invest's portfolio page · Not right? Tell us
How we know: henQ vc's portfolio page · Not right? Tell us
How we know: Inkef's portfolio page · funding news · tech.eu · the VCSheet dataset · Not right? Tell us
How we know: Northzone's portfolio page · funding news · tech.eu · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Rabo Corporate Venturing's portfolio page · Not right? Tell us
How we know: tech.eu · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AFeb 2019 · 2 sourcesSource ↗
- Undisclosed amountseed capitalJun 2017Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Aidence do?
- Aidence, founded in 2015 in Amsterdam, was a radiology AI company that built clinical applications to help radiologists and physicians interpret medical images, focused on pulmonary nodule management and lung cancer screening. Its main product, Veye Lung Nodules (now DeepHealth Lung), was a CE-marked AI solution for lung nodule detection, classification, quantification, and growth assessment; the company was acquired by RadNet in 2022 and integrated into DeepHealth.
- Who are Aidence's investors?
- Aidence's investors include HENQ Invest, henQ vc, Inkef, Northzone, Rabo Corporate Venturing, Rabo Ventures.
- Where is Aidence headquartered?
- Aidence is headquartered in Amsterdam, NL.